Advisor Group Holdings »

Enliven Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $28k 2.0k 13.84
2023-09-30 $27k 2.0k 13.66
2023-06-30 $20k 1.0k 20.41

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Enliven Therapeutics

OrbiMed Advisors
5AM Venture Management
VR Adviser
Commodore Capital
Citadel Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Boxer Capital
Henderson Group
Logos Global Management
Charles Schwab Investment Management
Bank of New York Mellon
BML Capital Management
Barclays

View all funds holding Enliven Therapeutics